Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality.
about
Conventional, molecular methods and biomarkers molecules in detection of septicemiaBiomarkers of sepsisTargeting C-Reactive Protein in Inflammatory Disease by Preventing Conformational ChangesMeasured Pulmonary and Systemic Markers of Inflammation and Oxidative Stress Following Wildland Firefighter SimulationsCytokine profiles in sepsis have limited relevance for stratifying patients in the emergency department: a prospective observational studyAlveolar pentraxin 3 as an early marker of microbiologically confirmed pneumonia: a threshold-finding prospective observational study.High plasma level of long pentraxin 3 (PTX3) is associated with fatal disease in bacteremic patients: a prospective cohort studyPentraxin 3 (PTX3) expression in allergic asthmatic airways: role in airway smooth muscle migration and chemokine productionHigh pentraxin-3 plasma levels associate with thrombocytopenia in acute Puumala hantavirus-induced nephropathia epidemica.The Dual Complexity of PTX3 in Health and Disease: A Balancing Act?A new surface plasmon resonance-based immunoassay for rapid, reproducible and sensitive quantification of pentraxin-3 in human plasmaSevere Acinetobacter baumannii sepsis is associated with elevation of pentraxin 3.Redox state of pentraxin 3 as a novel biomarker for resolution of inflammation and survival in sepsis.New approaches to sepsis: molecular diagnostics and biomarkers.Pentraxin 3 as a prognostic biomarker in patients with systemic inflammation or infection.Year in review in Intensive Care Medicine 2010: I. Acute renal failure, outcome, risk assessment and ICU performance, sepsis, neuro intensive care and experimentalsPentraxin 3 (PTX3) is associated with severe sepsis and fatal disease in emergency room patients with suspected infection: a prospective cohort studyA specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patientsPentraxin-3 serum levels are associated with disease severity and mortality in patients with systemic inflammatory response syndrome.Pathogen recognition by the long pentraxin PTX3.High pentraxin 3 level predicts septic shock and bacteremia at the onset of febrile neutropenia after intensive chemotherapy of hematologic patientsProtective molecules and their cognate antibodies: new players in autoimmunityThe protective role of TLR6 in a mouse model of asthma is mediated by IL-23 and IL-17A.Biomarkers of necrotising soft tissue infections: aspects of the innate immune response and effects of hyperbaric oxygenation-the protocol of the prospective cohort BIONEC studyAre there new approaches for diagnosis, therapy guidance and outcome prediction of sepsis?Pentraxin 3: a novel biomarker for inflammatory cardiovascular diseaseYear in review in Intensive Care Medicine 2011: I. Nephrology, epidemiology, nutrition and therapeutics, neurology, ethical and legal issues, experimentals.Pentraxin-3 as a marker of disease severity and risk of death in patients with necrotizing soft tissue infections: a nationwide, prospective, observational study.PTX3 controls activation of matrix metalloproteinase 1 and apoptosis in conjunctivochalasis fibroblasts.The proteomic profile of circulating pentraxin 3 (PTX3) complex in sepsis demonstrates the interaction with azurocidin 1 and other components of neutrophil extracellular trapsHost-protective effect of circulating pentraxin 3 (PTX3) and complex formation with neutrophil extracellular traps.Relationship of Inflammatory Biomarkers with Severity of Peripheral Arterial DiseaseLong Pentraxin 3 as a Predictive Marker of Mortality in Severe Septic Patients Who Received Successful Early Goal-Directed Therapy.Protective effects of long pentraxin PTX3 on lung injury in a severe acute respiratory syndrome model in mice.Pentraxin 3 plasma levels at graft-versus-host disease onset predict disease severity and response to therapy in children given haematopoietic stem cell transplantation.Established and novel biomarkers of sepsis.Biology of human pentraxin 3 (PTX3) in acute and chronic kidney disease.The long pentraxin PTX3: a paradigm for humoral pattern recognition molecules.Selected inflammatory markers in the diagnosis and monitoring of infections in children treated for hematological malignancies.Pentraxin 3: an immune modulator of infection and useful marker for disease severity assessment in sepsis.
P2860
Q26799362-7FBEF151-8121-4AF7-B31E-666B47F71F3AQ26822575-F3AA2229-327D-4B0F-AAD8-8FEF4DC90070Q26999377-D6F43437-EA66-448F-9FAF-424666409603Q28391773-2F9BB576-674E-4A28-8A71-2E446EE6EB1BQ28740685-93F921A7-DFCC-4CAA-ABCB-A73666F76D88Q30596839-7DCE37BE-0C0D-4D4B-99B9-2A6EA26A3D16Q31004218-41A2BCD1-027B-412D-AAF7-30ECCA3C9CADQ31057428-8E9D7940-E58B-4137-802F-DE53E0BAC871Q33397083-8449987B-C51A-461A-9556-FC2623733B2EQ33632047-694A0CA0-2204-4B3B-8ED5-6B48E9171193Q33986610-66D4D04D-6EC8-44B6-B928-5E3BD1821A87Q34298295-98F33C72-C4D6-4A06-805B-51EAAB2D5FBBQ34303331-64174A0A-DC22-440C-AC51-ED6061517FC0Q34303687-1B339200-745E-4DAF-BA38-0B4508DB7AD6Q34531258-ABDD1122-FF45-496F-AADE-57D99B53E6E8Q34534501-C24A3554-FB2C-430B-8A58-F5140049FD48Q34558563-E1DC0A6C-B597-4B8E-B488-705343423566Q34714685-5B6C65CD-B9B1-49D1-9248-8C830C699818Q34988829-D3A56F1B-A199-4FBB-86FF-4A17DD46BC32Q35054493-8D1076E7-AC7F-424B-B4A9-0DB1AD1D3C9FQ35193767-394324DB-7CB0-4D5C-B261-0F76760572E5Q35309510-1FE3C703-8D39-4373-864A-56C438CC7E50Q35484658-9185429E-655E-47BF-AB78-D7076E068A95Q35604874-FC7768D6-BC8C-4488-9C16-74E7CF2EA88DQ35622257-96BFF80D-60D8-4288-9895-1D21996862FBQ35755280-A35A4BA5-A6A3-4DF4-AE5F-466613CAA764Q35795306-49938222-7D6C-4D4E-928A-C67325CCA74CQ35924554-58CB0BB5-99B7-4BC6-A001-A5B37B454355Q36076997-A732B1C0-18BA-4593-BA3F-8A843ADC2F9EQ36209095-FA1BB9C6-0339-4891-8901-189F9B710DFFQ36463833-7D9CB23D-5EB8-4EC0-8985-90601EF5472DQ37172126-1AE39DAD-646B-4F21-8FC0-0EB74CAA357BQ37622160-75578F6F-DA57-41D8-B0AE-59DB6EAF7FBBQ37638963-E9004AEF-ACA7-4A83-B5F3-5AD14696ABB4Q37696092-A25C4A76-A0D2-4E6D-A051-CCAC47E08126Q37862741-605A5DCC-8169-4200-AE30-C07F14974031Q38084920-57F25F9D-525E-4D43-BD92-33557394FD66Q38092832-D51ED2BD-9D68-45D3-95A6-6179D177C8B0Q38488118-E493F536-7540-4128-85E8-75C226A4A24FQ38776706-A2919F5D-74B8-41D0-9AFC-203153C0D24B
P2860
Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Persisting high levels of plas ...... are associated with mortality.
@en
Persisting high levels of plas ...... are associated with mortality.
@nl
type
label
Persisting high levels of plas ...... are associated with mortality.
@en
Persisting high levels of plas ...... are associated with mortality.
@nl
prefLabel
Persisting high levels of plas ...... are associated with mortality.
@en
Persisting high levels of plas ...... are associated with mortality.
@nl
P2093
P2860
P50
P1476
Persisting high levels of plas ...... are associated with mortality
@en
P2093
Gaetano Iapichino
Giacomo Bellani
Giuseppe Peri
Ivan Cuccovillo
P2860
P2888
P304
P356
10.1007/S00134-010-1752-5
P50
P577
2010-01-30T00:00:00Z